ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Breakthroughs and Challenges of a New Era in ADPKD Care

ASN thanks the PKD Foundation for assistance with this program.

Course Description

Over the last three years, the management of patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) has fundamentally transformed through various advances. Diagnosis is often aided by low-cost next-generation sequencing platforms, and robust risk-stratification strategies identify high-risk patients who may benefit from recently approved treatments. Differences are emerging between ADPKD-specific supportive care and general CKD management. Translating these breakthroughs to clinical practice can be complicated.

This program efficiently addresses these breakthroughs and their accompanying challenges: the diagnostic and risk assessment tools, Food and Drug Administration (FDA) approvals, health disparities, and patient concerns. Formatted as an interactive practical guide, the on-demand presentations and live-stream session cover multiple aspects of the delivery of advanced ADPKD care.

All on-demand presentations will be available starting Monday, October 25. This program will feature one live, interactive session on Wednesday, October 28 which will be available on-demand after the live session. Note: There is no syllabus.

ASN designates this blended learning activity for a maximum of 8.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

(The credits total has been updated based on actual time.)

Course Objective(s)

Upon completion of the program, the participant will be able to: 1) describe how next-generation sequencing has transformed ADPKD care and enumerate its challenges; 2) outline strategies for ADPKD risk stratification; 3) explain how management of ADPKD kidney complications differs from that of other CKD; 4) describe common extrarenal ADPKD manifestations and their evaluation and management; and 5) identify the expectations patients with ADPKD have about their care.

Course Chair(s)

  • Michal Mrug, MD
  • Vishal Patel, MD


Register for this Early Program

Early Programs have limited capacity and fill up fast. Click the button below to register online.

Register Online